NCT04030442View on ClinicalTrials.gov

Cannabidiol, Morphine, Pain

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

January 26, 2025

Study Completion Date

January 26, 2025

Conditions
CBDChronic Pain
Interventions
DRUG

Immediate-release Oral Morphine Sulfate Tablets

0 mg Immediate release oral morphine; 15 mg Immediate release oral morphine; 30 mg Immediate release oral morphine; Randomized between sessions

OTHER

Thermal and Pressure Nociceptive Sensitivity

Primary outcome measures of pain threshold and tolerance.

Trial Locations (1)

48201

RECRUITING

Tolan Park Medical Building, Detroit

All Listed Sponsors
lead

Wayne State University

OTHER